Right to Try for Individualized Treatments Act
A bill to amend the Federal Food, Drug, and Cosmetic Act to authorize the use of investigational individualized medical treatments by patients diagnosed with a life-threatening disease or condition or severely debilitating illness, and for other purposes.
The Right to Try for Individualized Treatments Act proposes to change federal law so that people with serious, life-threatening, or severely debilitating conditions can use experimental treatments that are not yet fully approved by the FDA. This bill aims to give patients more options for care and potentially speed up the access to treatments that could help them.
This bill would affect patients with life-threatening or severely debilitating illnesses who may not have other treatment options. It would allow them to try experimental treatments that are still in the testing phase, giving them a chance to benefit from these treatments before they are officially approved. This could potentially improve the quality of life for these patients and provide them with more hope.
SB4698 was introduced on June 8, 2026, and referred to the Senate Committee on Health, Education, Labor, and Pensions. The bill is currently under review by this committee, which will decide the next steps in the legislative process. The key action so far has been its introduction and referral to the relevant committee.
